FDA Warning Letter — Zhejiang Huahai Pharmaceutical Co., Ltd.
The FDA took a Warning Letter action against Zhejiang Huahai Pharmaceutical Co., Ltd. on June 6, 2025 (Linhai, China). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Date
- June 6, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Center
- CDER
- Location
- Linhai (China)